Dose Consideration of Lenvatinib’s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy

Dose Consideration of Lenvatinib’s Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy

Purpose: The dose-dependent anti-cancer effect of lenvatinib on hepatocellular carcinoma (HCC) cells and the potential benefit of combined colchicine therapy were investigated. Methods: Four primary cultured HCC (S103, S143, S160, S176) cell lines were investigated by differential expressions of gen...

Full description

Bibliographic Details
Main Authors: Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, Po-Yao Hsu, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
colchicine
dose-dependent effect
hepatocellular carcinoma
lenvatinib
multikinase inhibitor
<i>NANOG</i>
Online Access:https://www.mdpi.com/2072-6694/15/20/5097

Internet

https://www.mdpi.com/2072-6694/15/20/5097

Similar Items